Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

434 matching registry records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:30 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3RecruitingINTERVENTIONAL

Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia

ClinicalTrials.gov · NCT06020495 · Registry updated: 2026-10-30

Condition / research focus: Hyponatremia
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2024-12-17. Completion: 2028-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

DDAVP (drug)
Standard hyponatremia treatment (drug)

Where the study takes place — 15 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Médecine Intensive et Réanimation - Centre Hospitalier Universitaire Amiens-Picardie
Amiens, France
Site recruitment: Recruiting
Néphrologie, dialyse et transplantation - Service de médecine intensive Réanimation, CHU Amiens-Picardie
Amiens, France
Site recruitment: Not yet recruiting
Médecine Intensive et Réanimation - Hôpital Avicenne
Bobigny, France
Site recruitment: Recruiting
Réanimation Polyvalente - Hôpital Jean Verdier
Bondy, France
Site recruitment: Recruiting
Médecine Intensive et Réanimation - Hôpital Louis Mourier
Colombes, France
Site recruitment: Recruiting
Réanimation Polyvalente et Surveillance continue - Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France
Site recruitment: Recruiting
Médecine Intensive et Réanimation - Hôpital Henri Mondor
Créteil, France
Site recruitment: Recruiting
Service de néphrologie - Soins intensifs - Dialyse - Transplantation, CHU Dijon
Dijon, France
Site recruitment: Not yet recruiting
Médecine Intensive et Réanimation - Hôpital François Mitterand
Dijon, France
Site recruitment: Recruiting
Réanimation Polyvalente - Centre Hospitalier Départemental Vendée
La Roche-sur-Yon, France
Site recruitment: Recruiting
Réanimation Polyvalente, CHR Metz Thionville - Hôpital de Mercy
Metz, France
Site recruitment: Recruiting
Réanimation Médicale - Hôpital de Paris Saclay
Orsay, France
Site recruitment: Recruiting
Médecine Intensive et Réanimation - Hôpital de la Pitié Salpêtrière
Paris, France
Site recruitment: Recruiting
Médecine Intensive Réanimation - Hôpital Delafontaine
Saint-Denis, France
Site recruitment: Recruiting
Réanimation Polyvalente - Hôpital Foch
Suresnes, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2Not yet recruitingINTERVENTIONAL

Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome

ClinicalTrials.gov · NCT07328529 · Registry updated: 2026-10-30

Condition / research focus: Aggressive Behavior in Fragile X Syndome
Sponsor: Azevan Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2026-12. Completion: 2028-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

SRX246 (drug)
Placebo (drug)

Where the study takes place — 3 listed sites

University of California, Davis, MIND Institute
Sacramento, California, United States
Site recruitment: Not reported
Rush University Medical Center
Chicago, Illinois, United States
Site recruitment: Not reported
Cincinnati Children's Hospital
Cincinnati, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2RecruitingINTERVENTIONAL

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

ClinicalTrials.gov · NCT05958342 · Registry updated: 2026-10-30

Condition / research focus: Trauma; Hemorrhage
Sponsor: Jason Sperry
Countries with listed sites: United States
Registry dates and results: Start: 2024-06-30. Completion: 2028-03 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Calcium Gluconate (drug)
Vasopressin (drug)
saline placebo (drug)

Where the study takes place — 18 listed sites

Chandler Regional Medical Center
Chandler, Arizona, United States
Site recruitment: Recruiting
University of Arizona
Tucson, Arizona, United States
Site recruitment: Recruiting
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Site recruitment: Recruiting
Zuckerberg San Francisco General Hospital and Trauma Center at University of California, San Francisco
San Francisco, California, United States
Site recruitment: Recruiting
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Site recruitment: Recruiting
Denver Health Medical Center
Denver, Colorado, United States
Site recruitment: Recruiting
University of Miami
Miami, Florida, United States
Site recruitment: Recruiting
University of Maryland, Baltimore
Baltimore, Maryland, United States
Site recruitment: Recruiting
Hennepin County Medical Center
Minneapolis, Minnesota, United States
Site recruitment: Recruiting
University of Mississippi Medical Center
Jackson, Mississippi, United States
Site recruitment: Recruiting
University of Missouri Health Care
Columbia, Missouri, United States
Site recruitment: Recruiting
University of New Mexico
Albuquerque, New Mexico, United States
Site recruitment: Recruiting
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States
Site recruitment: Recruiting
Mount Carmel East Hospital
Columbus, Ohio, United States
Site recruitment: Recruiting
Allegheny Health Network
Pittsburgh, Pennsylvania, United States
Site recruitment: Recruiting
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Site recruitment: Recruiting
Texas Tech University Health Sciences Center
Lubbock, Texas, United States
Site recruitment: Recruiting
University of Washington Harborview Medical Center
Seattle, Washington, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1 / Phase 2RecruitingINTERVENTIONAL

Vasopressin and Pain Perception in the Brain

ClinicalTrials.gov · NCT03446456 · Registry updated: 2026-10-28

Condition / research focus: Acute Pain
Sponsor: University of Maryland, Baltimore
Countries with listed sites: United States
Registry dates and results: Start: 2018-09-17. Completion: 2027-12-31 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Arginine vasopressin (drug) — also listed as: Arg8-vasopressin synthetic
Saline (other) — also listed as: Placebo
Observational learning (behavioral) — also listed as: Social observation
fMRI data aquisition (other)

Where the study takes place — 1 listed sites

Luana Colloca
Baltimore, Maryland, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:

ClinicalTrials.gov · NCT04501861 · Registry updated: 2026-10-27

Condition / research focus: Cardiac Disease
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2020-11-05. Completion: 2024-12-31 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Norepinephrine (drug)

Where the study takes place — 1 listed sites

Cleveland Clinic
Cleveland, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Cardiogenic Shock Working Group Registry

ClinicalTrials.gov · NCT04682483 · Registry updated: 2026-10-27

Condition / research focus: Cardiogenic Shock
Sponsor: Tufts Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2017-12-04. Completion: 2027-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressor (drug)
Inotrope (drug)
Acute Mechanical Circulatory Support Devices (device)

Where the study takes place — 16 listed sites

Cleveland Clinic Florida
Weston, Florida, United States
Site recruitment: Recruiting
Northwestern Medicine
Chicago, Illinois, United States
Site recruitment: Recruiting
University of Chicago
Chicago, Illinois, United States
Site recruitment: Recruiting
Maine Medical Center
Portland, Maine, United States
Site recruitment: Recruiting
Tufts Medical Center
Boston, Massachusetts, United States
Site recruitment: Recruiting
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Site recruitment: Recruiting
Hackensack Meridian Health
Hackensack, New Jersey, United States
Site recruitment: Recruiting
Columbia University Irving Medical Center
New York, New York, United States
Site recruitment: Recruiting
Providence St. Vincent Heart Clinic
Portland, Oregon, United States
Site recruitment: Recruiting
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Site recruitment: Recruiting
University Of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Site recruitment: Recruiting
Baylor Scott & White Advanced Heart Failure Clinic
Dallas, Texas, United States
Site recruitment: Recruiting
University of Texas Medical Branch
Galveston, Texas, United States
Site recruitment: Recruiting
Houston Methodist Hospital
Houston, Texas, United States
Site recruitment: Recruiting
Inova Health System
Falls Church, Virginia, United States
Site recruitment: Recruiting
University of Washington Medical Center
Seattle, Washington, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1RecruitingINTERVENTIONAL

Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency

ClinicalTrials.gov · NCT04789148 · Registry updated: 2026-10-26

Condition / research focus: Vasopressin Deficiency
Sponsor: Elizabeth Austen Lawson
Countries with listed sites: United States
Registry dates and results: Start: 2025-09-10. Completion: 2027-06 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (IN-OXT) 6 IU single dose (drug)
Intranasal Oxytocin (IN-OXT) 6 IU repeat dose (drug)
Placebo repeat dose (drug)
Intranasal Oxytocin (IN-OXT) 24 IU single dose (drug)
Placebo single dose (drug)

Where the study takes place — 1 listed sites

Massachusetts General Hospital, Neuroendocrine Unit
Boston, Massachusetts, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

Systematic Adjunction of Vasopressine in Septic Shock

ClinicalTrials.gov · NCT07052084 · Registry updated: 2026-10-26

Condition / research focus: Septic Shock
Sponsor: Assistance Publique Hopitaux De Marseille
Countries with listed sites: France
Registry dates and results: Start: 2026-03-24. Completion: 2028-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin administration (drug)
Sodium chloride administration (drug)

Where the study takes place — 3 listed sites

Centre Hospitalier du Pays d'Aix
Aix-en-Provence, France
Site recruitment: Recruiting
Assistance Publique - Hôpitaux de Marseille
Marseille, France
Site recruitment: Recruiting
CHU de Nîmes - Carémeau
Nîmes, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1RecruitingINTERVENTIONAL

Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

ClinicalTrials.gov · NCT07568509 · Registry updated: 2026-10-26

Condition / research focus: Arginine Vasopressin Deficiency; Oxytocin Deficiency; Pediatric Disease; Hypopituitarism
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2026-08-17. Completion: 2027-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Norethindrone Acetate-Ethinyl Estradiol (drug) — also listed as: Estrogen-progestin

Where the study takes place — 1 listed sites

Massachusetts General Hospital
Boston, Massachusetts, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Effects of Increased Water Intake on Hormonal Response, Hydration Status, and Physical Function in Low-drinking Older Adults

ClinicalTrials.gov · NCT07892742 · Registry updated: 2026-10-23

Condition / research focus: Dehydrated, Water-Electrolyte Imbalance, Malnutrition; Dehydration (Physiology)
Sponsor: Polytechnic University of Santarém
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-11-01. Completion: 2027-07-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Water (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4Enrolling by invitationINTERVENTIONAL

Phenotype Guided Vasoactive Medication During Kidney Transplantation

ClinicalTrials.gov · NCT07633600 · Registry updated: 2026-10-22

Condition / research focus: Kidney Transplant; Fluid Management
Sponsor: Jennifer Cutler
Countries with listed sites: United States
Registry dates and results: Start: 2026-06-01. Completion: 2027-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Phenotype-Guided Vasoactive Management (drug) — also listed as: Norepinephrine, Calcium Chloride, Dopamine, Vasopressin

Where the study takes place — 1 listed sites

Cedars Sinai Medical Center
Los Angeles, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Norepinephrine Equivalent Dose of Vasopressin, Phenylephrine and Epinephrine in Septic Shock

ClinicalTrials.gov · NCT06499467 · Registry updated: 2026-10-16

Condition / research focus: Septic Shock
Sponsor: Sanjay Gandhi Postgraduate Institute of Medical Sciences
Countries with listed sites: India
Registry dates and results: Start: 2024-07-12. Completion: 2026-01-30 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Sanjay Gandhi Postgraduate Institute of Medical Sciences
Lucknow, Uttar Pradesh, India
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Effect of Terlipressin on the Incidence of Early Postoperative Acute Kidney Injury in Liver Transplantation Patients

ClinicalTrials.gov · NCT06108362 · Registry updated: 2026-10-13

Condition / research focus: Acute Kidney Injury; Liver Transplant; Complications
Sponsor: Beijing Tsinghua Chang Gung Hospital
Countries with listed sites: China
Registry dates and results: Start: 2023-10-25. Completion: 2026-05-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug) — also listed as: Glypressin
normal saline (drug) — also listed as: normal sodium

Where the study takes place — 1 listed sites

Beijing Tsinghua Chang Gung Hospital
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Intracervical Vasopressin

ClinicalTrials.gov · NCT07102615 · Registry updated: 2026-10-02

Condition / research focus: Retained Products of Conception
Sponsor: Prisma Health-Upstate
Countries with listed sites: United States
Registry dates and results: Start: 2025-10-30. Completion: 2026-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intracervical injection of Vasopressin (drug)
Intracervical Injection of saline (drug)

Where the study takes place — 1 listed sites

The OB/GYN Center
Greenville, South Carolina, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Prophylactic Desmopressin Before Native Kidney Biopsy in Severe Renal Impairment

ClinicalTrials.gov · NCT07840313 · Registry updated: 2026-09-25

Condition / research focus: Severe Renal Impairment
Sponsor: Sindh Institute of Urology and Transplantation
Countries with listed sites: Pakistan
Registry dates and results: Start: 2017-08-01. Completion: 2017-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin Acetate (drug)
NO DESMOPRESSIN (other)

Where the study takes place — 1 listed sites

Sindh Institute of Urology and Transplantation (SIUT)
Karachi, Sindh, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Oromucosal Oxytocin and Vasopressin Modulation of Emotional Face Attention

ClinicalTrials.gov · NCT07838493 · Registry updated: 2026-09-24

Condition / research focus: Healhty
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2026-09-18. Completion: 2026-12-22 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (OT) (drug)
Arginine Vasopressin (AVP) (drug)
Placebo (PLC) (drug)

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China
Chengdu, Sichuang, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine

ClinicalTrials.gov · NCT07832032 · Registry updated: 2026-09-21

Condition / research focus: Migraine
Sponsor: Nordlandssykehuset HF
Countries with listed sites: Norway
Registry dates and results: Start: 2026-09-17. Completion: 2027-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Rimegepant 75 MG (drug) — also listed as: Vydura

Where the study takes place — 1 listed sites

Departement of Neurology, NLSH HF
Bodø, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST)

ClinicalTrials.gov · NCT02742974 · Registry updated: 2026-09-09

Condition / research focus: Critical Illness; Trauma
Sponsor: CAMC Health System
Countries with listed sites: United States
Registry dates and results: Start: 2015-10. Completion: 2017-11 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Device: FloTrac™ and EV1000™ (device)
Volume Challenge (other)
Vasopressor Therapy (drug)
Inotropic Therapy (drug)

Where the study takes place — 1 listed sites

Charleston Area Medical Center, General Hospital
Charleston, West Virginia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2RecruitingINTERVENTIONAL

Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome

ClinicalTrials.gov · NCT06635629 · Registry updated: 2026-08-31

Condition / research focus: Cushing Syndrome
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Countries with listed sites: United States
Registry dates and results: Start: 2024-12-12. Completion: 2029-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)
Dexamethasone (drug)

Where the study takes place — 1 listed sites

National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Early Versus Late Adjunctive Vasopressin in Septic Shock

ClinicalTrials.gov · NCT06709573 · Registry updated: 2026-08-31

Condition / research focus: Sepsis; Septic Shock
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2025-04-29. Completion: 2027-05-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

vasopressin - early initiation (drug) — also listed as: vasopressin
vasopressin - standard initiation (drug) — also listed as: vasopressin

Where the study takes place — 1 listed sites

Cleveland Clinic
Cleveland, Ohio, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

434 matching registry records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 17:30 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3RecruitingINTERVENTIONAL

Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia

ClinicalTrials.gov · NCT06020495 · Registry updated: 2026-10-30

Condition / research focus: Hyponatremia
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2024-12-17. Completion: 2028-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

DDAVP (drug)
Standard hyponatremia treatment (drug)

Where the study takes place — 15 listed sites

Médecine Intensive et Réanimation - Centre Hospitalier Universitaire Amiens-Picardie
Amiens, France
Site recruitment: Recruiting
Néphrologie, dialyse et transplantation - Service de médecine intensive Réanimation, CHU Amiens-Picardie
Amiens, France
Site recruitment: Not yet recruiting
Médecine Intensive et Réanimation - Hôpital Avicenne
Bobigny, France
Site recruitment: Recruiting
Réanimation Polyvalente - Hôpital Jean Verdier
Bondy, France
Site recruitment: Recruiting
Médecine Intensive et Réanimation - Hôpital Louis Mourier
Colombes, France
Site recruitment: Recruiting
Réanimation Polyvalente et Surveillance continue - Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France
Site recruitment: Recruiting
Médecine Intensive et Réanimation - Hôpital Henri Mondor
Créteil, France
Site recruitment: Recruiting
Service de néphrologie - Soins intensifs - Dialyse - Transplantation, CHU Dijon
Dijon, France
Site recruitment: Not yet recruiting
Médecine Intensive et Réanimation - Hôpital François Mitterand
Dijon, France
Site recruitment: Recruiting
Réanimation Polyvalente - Centre Hospitalier Départemental Vendée
La Roche-sur-Yon, France
Site recruitment: Recruiting
Réanimation Polyvalente, CHR Metz Thionville - Hôpital de Mercy
Metz, France
Site recruitment: Recruiting
Réanimation Médicale - Hôpital de Paris Saclay
Orsay, France
Site recruitment: Recruiting
Médecine Intensive et Réanimation - Hôpital de la Pitié Salpêtrière
Paris, France
Site recruitment: Recruiting
Médecine Intensive Réanimation - Hôpital Delafontaine
Saint-Denis, France
Site recruitment: Recruiting
Réanimation Polyvalente - Hôpital Foch
Suresnes, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2Not yet recruitingINTERVENTIONAL

Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome

ClinicalTrials.gov · NCT07328529 · Registry updated: 2026-10-30

Condition / research focus: Aggressive Behavior in Fragile X Syndome
Sponsor: Azevan Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2026-12. Completion: 2028-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

SRX246 (drug)
Placebo (drug)

Where the study takes place — 3 listed sites

University of California, Davis, MIND Institute
Sacramento, California, United States
Site recruitment: Not reported
Rush University Medical Center
Chicago, Illinois, United States
Site recruitment: Not reported
Cincinnati Children's Hospital
Cincinnati, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2RecruitingINTERVENTIONAL

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

ClinicalTrials.gov · NCT05958342 · Registry updated: 2026-10-30

Condition / research focus: Trauma; Hemorrhage
Sponsor: Jason Sperry
Countries with listed sites: United States
Registry dates and results: Start: 2024-06-30. Completion: 2028-03 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Calcium Gluconate (drug)
Vasopressin (drug)
saline placebo (drug)

Where the study takes place — 18 listed sites

Chandler Regional Medical Center
Chandler, Arizona, United States
Site recruitment: Recruiting
University of Arizona
Tucson, Arizona, United States
Site recruitment: Recruiting
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Site recruitment: Recruiting
Zuckerberg San Francisco General Hospital and Trauma Center at University of California, San Francisco
San Francisco, California, United States
Site recruitment: Recruiting
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Site recruitment: Recruiting
Denver Health Medical Center
Denver, Colorado, United States
Site recruitment: Recruiting
University of Miami
Miami, Florida, United States
Site recruitment: Recruiting
University of Maryland, Baltimore
Baltimore, Maryland, United States
Site recruitment: Recruiting
Hennepin County Medical Center
Minneapolis, Minnesota, United States
Site recruitment: Recruiting
University of Mississippi Medical Center
Jackson, Mississippi, United States
Site recruitment: Recruiting
University of Missouri Health Care
Columbia, Missouri, United States
Site recruitment: Recruiting
University of New Mexico
Albuquerque, New Mexico, United States
Site recruitment: Recruiting
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States
Site recruitment: Recruiting
Mount Carmel East Hospital
Columbus, Ohio, United States
Site recruitment: Recruiting
Allegheny Health Network
Pittsburgh, Pennsylvania, United States
Site recruitment: Recruiting
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Site recruitment: Recruiting
Texas Tech University Health Sciences Center
Lubbock, Texas, United States
Site recruitment: Recruiting
University of Washington Harborview Medical Center
Seattle, Washington, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1 / Phase 2RecruitingINTERVENTIONAL

Vasopressin and Pain Perception in the Brain

ClinicalTrials.gov · NCT03446456 · Registry updated: 2026-10-28

Condition / research focus: Acute Pain
Sponsor: University of Maryland, Baltimore
Countries with listed sites: United States
Registry dates and results: Start: 2018-09-17. Completion: 2027-12-31 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Arginine vasopressin (drug) — also listed as: Arg8-vasopressin synthetic
Saline (other) — also listed as: Placebo
Observational learning (behavioral) — also listed as: Social observation
fMRI data aquisition (other)

Where the study takes place — 1 listed sites

Luana Colloca
Baltimore, Maryland, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:

ClinicalTrials.gov · NCT04501861 · Registry updated: 2026-10-27

Condition / research focus: Cardiac Disease
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2020-11-05. Completion: 2024-12-31 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Norepinephrine (drug)

Where the study takes place — 1 listed sites

Cleveland Clinic
Cleveland, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Cardiogenic Shock Working Group Registry

ClinicalTrials.gov · NCT04682483 · Registry updated: 2026-10-27

Condition / research focus: Cardiogenic Shock
Sponsor: Tufts Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2017-12-04. Completion: 2027-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressor (drug)
Inotrope (drug)
Acute Mechanical Circulatory Support Devices (device)

Where the study takes place — 16 listed sites

Cleveland Clinic Florida
Weston, Florida, United States
Site recruitment: Recruiting
Northwestern Medicine
Chicago, Illinois, United States
Site recruitment: Recruiting
University of Chicago
Chicago, Illinois, United States
Site recruitment: Recruiting
Maine Medical Center
Portland, Maine, United States
Site recruitment: Recruiting
Tufts Medical Center
Boston, Massachusetts, United States
Site recruitment: Recruiting
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Site recruitment: Recruiting
Hackensack Meridian Health
Hackensack, New Jersey, United States
Site recruitment: Recruiting
Columbia University Irving Medical Center
New York, New York, United States
Site recruitment: Recruiting
Providence St. Vincent Heart Clinic
Portland, Oregon, United States
Site recruitment: Recruiting
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Site recruitment: Recruiting
University Of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Site recruitment: Recruiting
Baylor Scott & White Advanced Heart Failure Clinic
Dallas, Texas, United States
Site recruitment: Recruiting
University of Texas Medical Branch
Galveston, Texas, United States
Site recruitment: Recruiting
Houston Methodist Hospital
Houston, Texas, United States
Site recruitment: Recruiting
Inova Health System
Falls Church, Virginia, United States
Site recruitment: Recruiting
University of Washington Medical Center
Seattle, Washington, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1RecruitingINTERVENTIONAL

Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency

ClinicalTrials.gov · NCT04789148 · Registry updated: 2026-10-26

Condition / research focus: Vasopressin Deficiency
Sponsor: Elizabeth Austen Lawson
Countries with listed sites: United States
Registry dates and results: Start: 2025-09-10. Completion: 2027-06 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (IN-OXT) 6 IU single dose (drug)
Intranasal Oxytocin (IN-OXT) 6 IU repeat dose (drug)
Placebo repeat dose (drug)
Intranasal Oxytocin (IN-OXT) 24 IU single dose (drug)
Placebo single dose (drug)

Where the study takes place — 1 listed sites

Massachusetts General Hospital, Neuroendocrine Unit
Boston, Massachusetts, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

Systematic Adjunction of Vasopressine in Septic Shock

ClinicalTrials.gov · NCT07052084 · Registry updated: 2026-10-26

Condition / research focus: Septic Shock
Sponsor: Assistance Publique Hopitaux De Marseille
Countries with listed sites: France
Registry dates and results: Start: 2026-03-24. Completion: 2028-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin administration (drug)
Sodium chloride administration (drug)

Where the study takes place — 3 listed sites

Centre Hospitalier du Pays d'Aix
Aix-en-Provence, France
Site recruitment: Recruiting
Assistance Publique - Hôpitaux de Marseille
Marseille, France
Site recruitment: Recruiting
CHU de Nîmes - Carémeau
Nîmes, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1RecruitingINTERVENTIONAL

Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

ClinicalTrials.gov · NCT07568509 · Registry updated: 2026-10-26

Condition / research focus: Arginine Vasopressin Deficiency; Oxytocin Deficiency; Pediatric Disease; Hypopituitarism
Sponsor: Massachusetts General Hospital
Countries with listed sites: United States
Registry dates and results: Start: 2026-08-17. Completion: 2027-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Norethindrone Acetate-Ethinyl Estradiol (drug) — also listed as: Estrogen-progestin

Where the study takes place — 1 listed sites

Massachusetts General Hospital
Boston, Massachusetts, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Effects of Increased Water Intake on Hormonal Response, Hydration Status, and Physical Function in Low-drinking Older Adults

ClinicalTrials.gov · NCT07892742 · Registry updated: 2026-10-23

Condition / research focus: Dehydrated, Water-Electrolyte Imbalance, Malnutrition; Dehydration (Physiology)
Sponsor: Polytechnic University of Santarém
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-11-01. Completion: 2027-07-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Water (other)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4Enrolling by invitationINTERVENTIONAL

Phenotype Guided Vasoactive Medication During Kidney Transplantation

ClinicalTrials.gov · NCT07633600 · Registry updated: 2026-10-22

Condition / research focus: Kidney Transplant; Fluid Management
Sponsor: Jennifer Cutler
Countries with listed sites: United States
Registry dates and results: Start: 2026-06-01. Completion: 2027-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Phenotype-Guided Vasoactive Management (drug) — also listed as: Norepinephrine, Calcium Chloride, Dopamine, Vasopressin

Where the study takes place — 1 listed sites

Cedars Sinai Medical Center
Los Angeles, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Norepinephrine Equivalent Dose of Vasopressin, Phenylephrine and Epinephrine in Septic Shock

ClinicalTrials.gov · NCT06499467 · Registry updated: 2026-10-16

Condition / research focus: Septic Shock
Sponsor: Sanjay Gandhi Postgraduate Institute of Medical Sciences
Countries with listed sites: India
Registry dates and results: Start: 2024-07-12. Completion: 2026-01-30 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Sanjay Gandhi Postgraduate Institute of Medical Sciences
Lucknow, Uttar Pradesh, India
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Effect of Terlipressin on the Incidence of Early Postoperative Acute Kidney Injury in Liver Transplantation Patients

ClinicalTrials.gov · NCT06108362 · Registry updated: 2026-10-13

Condition / research focus: Acute Kidney Injury; Liver Transplant; Complications
Sponsor: Beijing Tsinghua Chang Gung Hospital
Countries with listed sites: China
Registry dates and results: Start: 2023-10-25. Completion: 2026-05-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug) — also listed as: Glypressin
normal saline (drug) — also listed as: normal sodium

Where the study takes place — 1 listed sites

Beijing Tsinghua Chang Gung Hospital
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Intracervical Vasopressin

ClinicalTrials.gov · NCT07102615 · Registry updated: 2026-10-02

Condition / research focus: Retained Products of Conception
Sponsor: Prisma Health-Upstate
Countries with listed sites: United States
Registry dates and results: Start: 2025-10-30. Completion: 2026-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intracervical injection of Vasopressin (drug)
Intracervical Injection of saline (drug)

Where the study takes place — 1 listed sites

The OB/GYN Center
Greenville, South Carolina, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Prophylactic Desmopressin Before Native Kidney Biopsy in Severe Renal Impairment

ClinicalTrials.gov · NCT07840313 · Registry updated: 2026-09-25

Condition / research focus: Severe Renal Impairment
Sponsor: Sindh Institute of Urology and Transplantation
Countries with listed sites: Pakistan
Registry dates and results: Start: 2017-08-01. Completion: 2017-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin Acetate (drug)
NO DESMOPRESSIN (other)

Where the study takes place — 1 listed sites

Sindh Institute of Urology and Transplantation (SIUT)
Karachi, Sindh, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Oromucosal Oxytocin and Vasopressin Modulation of Emotional Face Attention

ClinicalTrials.gov · NCT07838493 · Registry updated: 2026-09-24

Condition / research focus: Healhty
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2026-09-18. Completion: 2026-12-22 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (OT) (drug)
Arginine Vasopressin (AVP) (drug)
Placebo (PLC) (drug)

Where the study takes place — 1 listed sites

University of Electronic Science and Technology of China
Chengdu, Sichuang, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableNot yet recruitingOBSERVATIONAL

Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine

ClinicalTrials.gov · NCT07832032 · Registry updated: 2026-09-21

Condition / research focus: Migraine
Sponsor: Nordlandssykehuset HF
Countries with listed sites: Norway
Registry dates and results: Start: 2026-09-17. Completion: 2027-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Rimegepant 75 MG (drug) — also listed as: Vydura

Where the study takes place — 1 listed sites

Departement of Neurology, NLSH HF
Bodø, Norway
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST)

ClinicalTrials.gov · NCT02742974 · Registry updated: 2026-09-09

Condition / research focus: Critical Illness; Trauma
Sponsor: CAMC Health System
Countries with listed sites: United States
Registry dates and results: Start: 2015-10. Completion: 2017-11 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Device: FloTrac™ and EV1000™ (device)
Volume Challenge (other)
Vasopressor Therapy (drug)
Inotropic Therapy (drug)

Where the study takes place — 1 listed sites

Charleston Area Medical Center, General Hospital
Charleston, West Virginia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2RecruitingINTERVENTIONAL

Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome

ClinicalTrials.gov · NCT06635629 · Registry updated: 2026-08-31

Condition / research focus: Cushing Syndrome
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Countries with listed sites: United States
Registry dates and results: Start: 2024-12-12. Completion: 2029-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin (drug)
Dexamethasone (drug)

Where the study takes place — 1 listed sites

National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Early Versus Late Adjunctive Vasopressin in Septic Shock

ClinicalTrials.gov · NCT06709573 · Registry updated: 2026-08-31

Condition / research focus: Sepsis; Septic Shock
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2025-04-29. Completion: 2027-05-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

vasopressin - early initiation (drug) — also listed as: vasopressin
vasopressin - standard initiation (drug) — also listed as: vasopressin

Where the study takes place — 1 listed sites

Cleveland Clinic
Cleveland, Ohio, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →